JP2011507856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011507856A5 JP2011507856A5 JP2010539512A JP2010539512A JP2011507856A5 JP 2011507856 A5 JP2011507856 A5 JP 2011507856A5 JP 2010539512 A JP2010539512 A JP 2010539512A JP 2010539512 A JP2010539512 A JP 2010539512A JP 2011507856 A5 JP2011507856 A5 JP 2011507856A5
- Authority
- JP
- Japan
- Prior art keywords
- connexin
- medicament
- composition
- medicament according
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US866007P | 2007-12-21 | 2007-12-21 | |
| PCT/US2008/014020 WO2009085269A2 (en) | 2007-12-21 | 2008-12-22 | Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014124291A Division JP2014169330A (ja) | 2007-12-21 | 2014-06-17 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011507856A JP2011507856A (ja) | 2011-03-10 |
| JP2011507856A5 true JP2011507856A5 (https=) | 2013-04-25 |
Family
ID=40824954
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010539512A Withdrawn JP2011507856A (ja) | 2007-12-21 | 2008-12-22 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
| JP2014124291A Withdrawn JP2014169330A (ja) | 2007-12-21 | 2014-06-17 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
| JP2016169310A Pending JP2017025076A (ja) | 2007-12-21 | 2016-08-31 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014124291A Withdrawn JP2014169330A (ja) | 2007-12-21 | 2014-06-17 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
| JP2016169310A Pending JP2017025076A (ja) | 2007-12-21 | 2016-08-31 | 整形外科状態の治療のための抗コネキシンポリヌクレオチド、ペプチド、または抗体の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110217313A1 (https=) |
| EP (1) | EP2238250B1 (https=) |
| JP (3) | JP2011507856A (https=) |
| AU (1) | AU2008343840A1 (https=) |
| CA (1) | CA2710375A1 (https=) |
| WO (1) | WO2009085269A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102073629B1 (ko) | 2005-02-03 | 2020-02-05 | 코다 테라퓨틱스 (엔지) 리미티드 | 항-코넥신 화합물 및 그의 용도 |
| US8975237B2 (en) | 2007-12-21 | 2015-03-10 | Coda Therapeutics, Inc. | Treatment of fibrotic conditions |
| DK2819682T3 (en) | 2012-03-01 | 2017-08-21 | Firststring Res Inc | TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES |
| WO2013148736A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
| CN107109410B (zh) | 2014-08-22 | 2021-11-02 | 奥克兰联合服务有限公司 | 通道调节剂 |
| CA3022763A1 (en) * | 2016-05-03 | 2017-11-09 | University Of Auckland | Novel peptides and peptidomimetics |
| CA3061738A1 (en) | 2017-04-28 | 2018-11-01 | Auckland Uniservices Limited | Methods of treatment and novel constructs |
| MX2023004631A (es) | 2020-10-22 | 2023-07-20 | Xequel Bio Inc | Formulaciones peptidicas y usos oftalmicos de las mismas. |
| WO2022103638A1 (en) * | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Cannabinoids in the treatment of autism spectrum disorder |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1322714C (en) * | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
| US5004810A (en) * | 1988-09-30 | 1991-04-02 | Schering Corporation | Antiviral oligomers |
| US5166195A (en) * | 1990-05-11 | 1992-11-24 | Isis Pharmaceuticals, Inc. | Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides |
| GB9206861D0 (en) * | 1992-03-28 | 1992-05-13 | Univ Manchester | Wound healing and treatment of fibrotic disorders |
| US6566339B1 (en) * | 1995-08-04 | 2003-05-20 | Renovo Limited | Pharmaceutical composition |
| GB2304047A (en) * | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| EP1486565B1 (en) * | 1995-10-11 | 2007-11-21 | Novartis Vaccines and Diagnostics, Inc. | Combination of PDGF, KGF, IGF, and IGFBP for wound healing |
| EP1806131A3 (en) * | 1996-07-22 | 2007-08-01 | Renovo Limited | Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| GB9702943D0 (en) * | 1997-02-13 | 1997-04-02 | Univ Manchester | Wound healing |
| US6855505B2 (en) * | 1998-06-26 | 2005-02-15 | Renovo Limited | Method for quantifying TGF-β |
| EP2314321B1 (en) * | 1999-01-27 | 2014-06-04 | Coda Therapeutics, Inc. | Formulations comprising antisense nucleotides to connexins |
| GB9903598D0 (en) * | 1999-02-18 | 1999-04-07 | Univ Manchester | Connective tissue healing |
| US7250397B2 (en) * | 2000-02-23 | 2007-07-31 | Zealand Pharma A/S | Antiarrhythmic peptides |
| CN1638790A (zh) * | 2002-01-29 | 2005-07-13 | Wyeth公司 | 用于调节连接蛋白半通道的组合物和方法 |
| CA2536096A1 (en) * | 2004-01-30 | 2005-08-18 | Angiotech International Ag | Compositions and methods for treating contracture |
| KR102073629B1 (ko) * | 2005-02-03 | 2020-02-05 | 코다 테라퓨틱스 (엔지) 리미티드 | 항-코넥신 화합물 및 그의 용도 |
| JP5240925B2 (ja) * | 2005-05-25 | 2013-07-17 | カロシン ファーマ， インコーポレイテッド | 変形性関節症を処置するための方法および組成物 |
| US7767710B2 (en) * | 2005-05-25 | 2010-08-03 | Calosyn Pharma, Inc. | Method for treating osteoarthritis |
| WO2009085271A2 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions |
-
2008
- 2008-12-22 AU AU2008343840A patent/AU2008343840A1/en not_active Abandoned
- 2008-12-22 WO PCT/US2008/014020 patent/WO2009085269A2/en not_active Ceased
- 2008-12-22 US US12/809,902 patent/US20110217313A1/en not_active Abandoned
- 2008-12-22 JP JP2010539512A patent/JP2011507856A/ja not_active Withdrawn
- 2008-12-22 CA CA2710375A patent/CA2710375A1/en not_active Abandoned
- 2008-12-22 EP EP08866608.6A patent/EP2238250B1/en not_active Not-in-force
-
2014
- 2014-06-17 JP JP2014124291A patent/JP2014169330A/ja not_active Withdrawn
-
2016
- 2016-08-31 JP JP2016169310A patent/JP2017025076A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011507856A5 (https=) | ||
| JP2021063107A (ja) | ミオスタチン阻害剤の使用および併用療法 | |
| JP2011507858A5 (https=) | ||
| CZ29723U1 (cs) | Nízkofrekvenční terapie s glatiramer acetátem | |
| Moola et al. | Attempting primary closure for all open fractures: the effectiveness of an institutional protocol | |
| Doubravska et al. | Incidence of postoperative nausea and vomiting in patients at a university hospital. Where are we today | |
| Hildebrand et al. | Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures | |
| JP2011507859A5 (https=) | ||
| Zhou et al. | Effects of electroacupuncture on bone mass and cathepsin K expression in ovariectomised rats | |
| Schnetzke et al. | Vascular impulse technology versus elevation for the reduction of swelling of lower extremity joint fractures: results of a prospective randomized controlled study | |
| Dunn et al. | Biomimetic sponges improve functional muscle recovery following composite trauma | |
| Öztürk et al. | Efficacy of extracorporeal shock wave and pulse electromagnetic field therapies in calcaneal spurs | |
| Russo et al. | Conservative integrated treatment of adhesive capsulitis of the shoulder | |
| CA3219312A1 (en) | Presurgical perineural administration of resiniferatoxin for reduction of post-operative pain | |
| TW202504617A (zh) | 治療對卡介苗療法無反應的高風險非肌肉侵襲性膀胱癌之方法 | |
| Rushing | Lower extremity orthopedic augmentation utilizing a synthetic hybrid-scale fiber matrix | |
| Juthberg et al. | Which leg immobilized patient gains the most from Intermittent Pneumatic Compression in DVT-prevention? | |
| Li et al. | Scheduled injection of ramosetron for prevention of nausea and vomiting following single-port access total laparoscopic hysterectomy: a prospective randomized study | |
| Liu et al. | Influence of tourniquet on wound healing in total knee arthroplasty: a randomized and paired clinical trial | |
| Ding et al. | Treatment of acute and closed Achilles tendon ruptures by minimally invasive tenocutaneous suturing | |
| Jain et al. | Comparison between dexmedetomidine and clonidine as an adjuvant to spinal anesthesia in abdominal hysterectomy | |
| Honeybul et al. | Skull vault destruction after rhinocerebral mucormycosis | |
| RU2354383C2 (ru) | Способ лечения перонеального синдрома | |
| Oh et al. | Concurrence of palmoplantar psoriasiform eruptions and hair loss during carbamazepine treatment | |
| Van Tongel et al. | Fracture of the posterior medial tubercle of the talus: a case report and review of the literature |